Key statistics
On Friday, Kronos Bio Inc (KRON:NSQ) closed at 0.825, 19.57% above the 52 week low of 0.69 set on May 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.8703 |
---|---|
High | 0.92 |
Low | 0.825 |
Bid | 0.83 |
Offer | 0.95 |
Previous close | 0.90 |
Average volume | 73.00k |
---|---|
Shares outstanding | 60.29m |
Free float | 44.07m |
P/E (TTM) | -- |
Market cap | 49.74m USD |
EPS (TTM) | -1.75 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
- Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma
- Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors
- Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors
- Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease
- Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy
- Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer
- Kronos Bio Announces Participation in Medical and Investor Conferences in September
- Kronos Bio Reports Second Quarter 2024 Financial Results and Pipeline Update
- Kronos Bio Announces First Patient Dosed with KB-0742 in an Expansion Cohort Focused on Platinum-Resistant High-Grade Serous Ovarian Cancer
- Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
More ▼